content: <?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:d7e841c6-43c0-40df-a1fd-37b51afaee3e,g:2d53a583-9ef7-49c5-90b7-abf69e452785,d:7829c60a0d404b9e90b092270a84929d--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>
  
  
  <title>cah-20210312</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF80L2ZyYWc6YjM4NjQ2NTk4OWQ3NGE0MWE1ZTI1NTU2MzU1NTA4MTIvdGFibGU6NWQ2YWRiMjQ4YWIwNDEzZWE1YmI2NTQ0ZDI2MWFjY2QvdGFibGVyYW5nZTo1ZDZhZGIyNDhhYjA0MTNlYTViYjY1NDRkMjYxYWNjZF8xLTEtMS0xLTA_b6bdf3e7-4f53-4ab3-9af6-00a6c25ff3a4">0000721371</ix:nonNumeric><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF80L2ZyYWc6YjM4NjQ2NTk4OWQ3NGE0MWE1ZTI1NTU2MzU1NTA4MTIvdGFibGU6NWQ2YWRiMjQ4YWIwNDEzZWE1YmI2NTQ0ZDI2MWFjY2QvdGFibGVyYW5nZTo1ZDZhZGIyNDhhYjA0MTNlYTViYjY1NDRkMjYxYWNjZF8yLTEtMS0xLTA_f589caeb-43c8-49d9-8b4a-9ee66d91fc8a">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cah-20210312.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7829c60a0d404b9e90b092270a84929d_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:24pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:24pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Washington,&#160;D.C. 20549</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:18pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGV4dHJlZ2lvbjowNmJkNzFmZjI5NTc0NGEwYTc2YzE2NWQ1Y2U4ZDJlNV8xMjY3_a9d1ab9a-75f9-409c-8f46-afa4a7a0d20d">8-K</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Current Report</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-bottom:0.5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGV4dHJlZ2lvbjowNmJkNzFmZjI5NTc0NGEwYTc2YzE2NWQ1Y2U4ZDJlNV8yMjY_1445bef5-26ef-4d4c-ac4f-a1697de98688">March 12, 2021</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:46.783%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                         </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGV4dHJlZ2lvbjowNmJkNzFmZjI5NTc0NGEwYTc2YzE2NWQ1Y2U4ZDJlNV8xMjY4_45ccef2f-34b6-4c9c-98fd-d0fbf820d130">Cardinal Health, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:31.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.425%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.907%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.121%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.254%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGFibGU6NWMwYmJiYjM2NDA5NGZjNWFjMGVhZDU0ODBmYThmNjkvdGFibGVyYW5nZTo1YzBiYmJiMzY0MDk0ZmM1YWMwZWFkNTQ4MGZhOGY2OV8xLTAtMS0xLTA_f422a4c2-54c1-4d2b-920e-ca12ae7e5f64">Ohio</ix:nonNumeric></span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGFibGU6NWMwYmJiYjM2NDA5NGZjNWFjMGVhZDU0ODBmYThmNjkvdGFibGVyYW5nZTo1YzBiYmJiMzY0MDk0ZmM1YWMwZWFkNTQ4MGZhOGY2OV8xLTEtMS0xLTA_e9c8f0dc-c92e-49b2-bda9-189f41772092">1-11373</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGFibGU6NWMwYmJiYjM2NDA5NGZjNWFjMGVhZDU0ODBmYThmNjkvdGFibGVyYW5nZTo1YzBiYmJiMzY0MDk0ZmM1YWMwZWFkNTQ4MGZhOGY2OV8xLTktMS0xLTA_5661e098-4049-4519-9d2b-fc65b467c59b">31-0958666</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other<br/>jurisdiction of incorporation)</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">File Number)</span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGV4dHJlZ2lvbjowNmJkNzFmZjI5NTc0NGEwYTc2YzE2NWQ1Y2U4ZDJlNV8xMjY5_693ded3e-3d2d-4625-a35a-e5c487a266a9">7000 Cardinal Place</ix:nonNumeric>, <ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGV4dHJlZ2lvbjowNmJkNzFmZjI5NTc0NGEwYTc2YzE2NWQ1Y2U4ZDJlNV8xMjYy_b779edf7-8d51-48cf-9304-602aa53cecec">Dublin</ix:nonNumeric>, <ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGV4dHJlZ2lvbjowNmJkNzFmZjI5NTc0NGEwYTc2YzE2NWQ1Y2U4ZDJlNV8xMjYz_8957b36e-f2e8-4433-bdb3-8d0fa2aff6c6">Ohio</ix:nonNumeric> <ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGV4dHJlZ2lvbjowNmJkNzFmZjI5NTc0NGEwYTc2YzE2NWQ1Y2U4ZDJlNV8xMjY0_3d5006d3-3d75-4f55-b77f-3cca149e8e79">43017</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGV4dHJlZ2lvbjowNmJkNzFmZjI5NTc0NGEwYTc2YzE2NWQ1Y2U4ZDJlNV8xMjY1_95dffe52-35cf-4343-9179-e5e24a207894">614</ix:nonNumeric>) <ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGV4dHJlZ2lvbjowNmJkNzFmZjI5NTc0NGEwYTc2YzE2NWQ1Y2U4ZDJlNV8xMjY2_eb58b060-4b39-40a2-966e-bf6e184cd080">757-5000</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:0.5pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">see</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instructions A.2. below):</span></div><div style="margin-bottom:5.5pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGFibGU6MjUxNjU2MjhkYzAyNGI0MmIyNzFiYWQwODliNGIxM2IvdGFibGVyYW5nZToyNTE2NTYyOGRjMDI0YjQyYjI3MWJhZDA4OWI0YjEzYl8wLTAtMS0xLTA_75404848-27e0-4e24-b178-63e820ad3c04">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGFibGU6MjUxNjU2MjhkYzAyNGI0MmIyNzFiYWQwODliNGIxM2IvdGFibGVyYW5nZToyNTE2NTYyOGRjMDI0YjQyYjI3MWJhZDA4OWI0YjEzYl8yLTAtMS0xLTA_3c7e98f4-d7c7-4775-b6f7-f2b6e4c78243">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGFibGU6MjUxNjU2MjhkYzAyNGI0MmIyNzFiYWQwODliNGIxM2IvdGFibGVyYW5nZToyNTE2NTYyOGRjMDI0YjQyYjI3MWJhZDA4OWI0YjEzYl80LTAtMS0xLTA_6ec8892b-43ce-44ab-8a30-3764ed5fd18a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGFibGU6MjUxNjU2MjhkYzAyNGI0MmIyNzFiYWQwODliNGIxM2IvdGFibGVyYW5nZToyNTE2NTYyOGRjMDI0YjQyYjI3MWJhZDA4OWI0YjEzYl82LTAtMS0xLTA_1d832c4b-8a49-41cf-8c55-74f84d29ae60">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGFibGU6ZjdmYzU5YjhlY2RhNGEyNzkwMjczOTkxM2QzMjMwOTgvdGFibGVyYW5nZTpmN2ZjNTliOGVjZGE0YTI3OTAyNzM5OTEzZDMyMzA5OF8yLTAtMS0xLTA_f59cf7f6-badd-4e13-aae1-bffbebebc3f3">Common shares (without par value)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGFibGU6ZjdmYzU5YjhlY2RhNGEyNzkwMjczOTkxM2QzMjMwOTgvdGFibGVyYW5nZTpmN2ZjNTliOGVjZGE0YTI3OTAyNzM5OTEzZDMyMzA5OF8yLTEtMS0xLTA_ae5a2678-cd59-4793-9ec3-661dd1be7a55">CAH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGFibGU6ZjdmYzU5YjhlY2RhNGEyNzkwMjczOTkxM2QzMjMwOTgvdGFibGVyYW5nZTpmN2ZjNTliOGVjZGE0YTI3OTAyNzM5OTEzZDMyMzA5OF8yLTItMS0xLTA_201cd63b-5719-41bb-9910-8c3a782ff50c">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:34.210%"><tr><td style="width:1.0%"></td><td style="width:79.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia320a8939edf4e2880dae4fcbbcb398c_D20210205-20210205" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjc4MjljNjBhMGQ0MDRiOWU5MGIwOTIyNzBhODQ5MjlkL3NlYzo3ODI5YzYwYTBkNDA0YjllOTBiMDkyMjcwYTg0OTI5ZF8xL2ZyYWc6MDZiZDcxZmYyOTU3NDRhMGE3NmMxNjVkNWNlOGQyZTUvdGFibGU6OTM3OTdmMWUxY2UxNGRhZjg5Mjg4NmJjMGI2NjRmMzMvdGFibGVyYW5nZTo5Mzc5N2YxZTFjZTE0ZGFmODkyODg2YmMwYjY2NGYzM18wLTEtMS0xLTA_5522d5c0-769c-4fd9-8e27-6cf83712265a">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">p</span></div><div style="margin-bottom:5pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i7829c60a0d404b9e90b092270a84929d_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 2.05: Costs Associated with Exit or Disposal Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, Cardinal Health, Inc. (the &#8220;Company&#8221;) entered into a definitive agreement to sell its Cordis business (the &#8220;planned divestiture&#8221;). In connection with the planned divestiture, the Company has been authorized to incur costs associated with exit or disposal activities of up to $125 million. The Company expects to record these charges in the </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring and employee severance</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">line item in its statement of earnings primarily during its fiscal years 2021 and 2022. The Company expects these charges to consist of approximately $83 million of professional, project management and other service fees to support the planned divestiture; $19 million of employee-related costs; and additional expenses from facility exits and other restructuring activities. The Company expects the majority of these costs to result in future cash expenditures. All of the estimates described in Item 2.05 of this Form 8-K may change in the future.</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div id="i7829c60a0d404b9e90b092270a84929d_174"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 2.06: Material Impairment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the entry into the definitive agreement described above in Item 2.05, in the quarter ended March 31, 2021, the Company will classify the Cordis business as held for sale and will write down the net assets being sold to fair value less costs to sell, which the Company expects will result in a pre-tax loss not in excess of $120 million. The Company does not anticipate that this charge will result in future cash expenditures. All of the estimates described in Item 2.06 of this Form 8-K may change in the future. </span></div><div id="i7829c60a0d404b9e90b092270a84929d_10"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 7.01: Regulation FD Disclosure</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The news release announcing the planned divestiture discussed above in Item 2.05 is being furnished as Exhibit 99.1 to this Form 8-K and additional information posted on the Company&#8217;s Investor Relations website is being furnished as Exhibit 99.2.</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div id="i7829c60a0d404b9e90b092270a84929d_180"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 8.01: Other Events</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February 26, 2021, the Company received a subpoena from the U.S. Securities and Exchange Commission requesting the production of documents from 2015 through 2019 relating to inventory in the Cordis business, analysis of goodwill of the Medical segment and other matters. The Company is cooperating with the SEC&#8217;s inquiry and cannot predict its duration or outcome.</span></div><div id="i7829c60a0d404b9e90b092270a84929d_13"></div><div style="-sec-extract:summary;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 9.01: Financial Statements and Exhibits</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.505%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a21q3_8kx031021xex-buyerx.htm">News release issued by the Company on March 12, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a21q3_x031021xex992xnewsre.htm">Additional Information regarding planned divestiture posted to ir.cardinalhealth.com on March 12, 2021</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="i7829c60a0d404b9e90b092270a84929d_190"></div><div><span style="color:#333333;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cautions Concerning Forward-Looking Statements</span></div><div><span><br/></span></div><div><span style="color:#333333;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Form 8-K contains forward-looking statements addressing Cardinal Health's plans to divest the Cordis business and the financial impact to Cardinal Health resulting therefrom, as well as other statements about future expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results, trends or guidance, statements of outlook and expense accruals. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include: the ability to successfully complete the divestiture of the Cordis business on a timely basis, including receipt of required regulatory approvals and satisfaction of other conditions; the risk that the costs associated with exit or disposal activities could ultimately be greater than we currently expect; the risk that impairment of the transferred assets could ultimately be greater than we currently expect; and the possibility that the divestiture could result in an impairment of our remaining Medical unit goodwill. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This release reflects management's views as of March 12, 2021. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i7829c60a0d404b9e90b092270a84929d_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Signatures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardinal Health, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JASON M. HOLLAR</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason M. Hollar </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div></body></html>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "cah-20210312.htm", "description": "8-K", "secsgml_size_bytes": 41391}]
metadata_filer: {"company-data": {"conformed-name": "CARDINAL HEALTH INC", "cik": "0000721371", "assigned-sic": "5122", "irs-number": "310958666", "state-of-incorporation": "OH", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11373", "film-number": "21735581"}, "business-address": {"street1": "7000 CARDINAL PLACE", "city": "DUBLIN", "state": "OH", "zip": "43017", "phone": "6147573033"}, "mail-address": {"street1": "7000 CARDINAL PLACE", "city": "DUBLIN", "state": "OH", "zip": "43017"}, "former-company": {"former-conformed-name": "CARDINAL DISTRIBUTION INC", "date-changed": "19920703"}}
text: cah-20210312
  UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM
  8-K
  Current Report
  Pursuant to Section 13 or 15(d) of the
  Securities Exchange Act of 1934
  Date of Report (Date of earliest event reported):
  March 12, 2021
  Cardinal Health, Inc.
  (Exact name of registrant as specified in its charter)
  Ohio
  1-11373
  31-0958666
  (State or other
  jurisdiction of incorporation)
  (Commission
  File Number)
  (IRS Employer
  Identification No.)
  7000 Cardinal Place
  ,
  Dublin
  ,
  Ohio
  43017
  (
  614
  )
  757-5000
  (Registrant's telephone number, including area code)
  Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
  see
  General Instructions A.2. below):
  ☐
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  ☐
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  ☐
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  ☐
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  Securities registered pursuant to Section 12(b) of the Act:
  Title of each class
  Trading Symbol(s)
  Name of each exchange on which registered
  Common shares (without par value)
  CAH
  New York Stock Exchange
  Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
  Emerging growth company
  ☐
  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
  p
  Item 2.05: Costs Associated with Exit or Disposal Activities
  On March 12, 2021, Cardinal Health, Inc. (the "Company") entered into a definitive agreement to sell its Cordis business (the "planned divestiture"). In connection with the planned divestiture, the Company has been authorized to incur costs associated with exit or disposal activities of up to $125 million. The Company expects to record these charges in the
  Restructuring and employee severance
  line item in its statement of earnings primarily during its fiscal years 2021 and 2022. The Company expects these charges to consist of approximately $83 million of professional, project management and other service fees to support the planned divestiture; $19 million of employee-related costs; and additional expenses from facility exits and other restructuring activities. The Company expects the majority of these costs to result in future cash expenditures. All of the estimates described in Item 2.05 of this Form 8-K may change in the future.
  Item 2.06: Material Impairment
  In connection with the entry into the definitive agreement described above in Item 2.05, in the quarter ended March 31, 2021, the Company will classify the Cordis business as held for sale and will write down the net assets being sold to fair value less costs to sell, which the Company expects will result in a pre-tax loss not in excess of $120 million. The Company does not anticipate that this charge will result in future cash expenditures. All of the estimates described in Item 2.06 of this Form 8-K may change in the future.
  Item 7.01: Regulation FD Disclosure
  The news release announcing the planned divestiture discussed above in Item 2.05 is being furnished as Exhibit 99.1 to this Form 8-K and additional information posted on the Company's Investor Relations website is being furnished as Exhibit 99.2.
  Item 8.01: Other Events
  On February 26, 2021, the Company received a subpoena from the U.S. Securities and Exchange Commission requesting the production of documents from 2015 through 2019 relating to inventory in the Cordis business, analysis of goodwill of the Medical segment and other matters. The Company is cooperating with the SEC's inquiry and cannot predict its duration or outcome.
  Item 9.01: Financial Statements and Exhibits
  (d) Exhibits
  Exhibit
  Number
  Exhibit Description
  99.1
  News release issued by the Company on March 12, 2021
  99.2
  Additional Information regarding planned divestiture posted to ir.cardinalhealth.com on March 12, 2021
  Cautions Concerning Forward-Looking Statements
  This Form 8-K contains forward-looking statements addressing Cardinal Health's plans to divest the Cordis business and the financial impact to Cardinal Health resulting therefrom, as well as other statements about future expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results, trends or guidance, statements of outlook and expense accruals. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include: the ability to successfully complete the divestiture of the Cordis business on a timely basis, including receipt of required regulatory approvals and satisfaction of other conditions; the risk that the costs associated with exit or disposal activities could ultimately be greater than we currently expect; the risk that impairment of the transferred assets could ultimately be greater than we currently expect; and the possibility that the divestiture could result in an impairment of our remaining Medical unit goodwill. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This release reflects management's views as of March 12, 2021. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement.
  2
  Signatures
  Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  Cardinal Health, Inc.
  (Registrant)
  Date:
  March 12, 2021
  By:
  /s/    JASON M. HOLLAR
  Jason M. Hollar
  Chief Financial Officer
  3